Literature DB >> 20949337

Prophylactic citalopram treatment in hepatitis C patients on antiviral therapy: Will it limit drug-induced depression and enhance adherence?

Thomas N Wise1.   

Abstract

Entities:  

Year:  2011        PMID： 20949337     DOI： 10.1007/s11920-010-0161-3

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  3 in total

1.  Paroxetine for the prevention of depression induced by high-dose interferon alfa.

Authors:  D L Musselman; D H Lawson; J F Gumnick; A K Manatunga; S Penna; R S Goodkin; K Greiner; C B Nemeroff; A H Miller
Journal:  N Engl J Med       Date:  2001-03-29       Impact factor: 91.245

2.  Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.

Authors:  Martin Schaefer; Markus Schwaiger; Andrea S Garkisch; Maurice Pich; Axel Hinzpeter; Ralf Uebelhack; Andreas Heinz; Florian van Boemmel; Thomas Berg
Journal:  J Hepatol       Date:  2005-04-02       Impact factor: 25.083

3.  A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C.

Authors:  Benjamin J Morasco; Muhamad Aly Rifai; Jennifer M Loftis; David W Indest; James Kelly Moles; Peter Hauser
Journal:  J Affect Disord       Date:  2007-02-09       Impact factor: 4.839
  3 in total
  1 in total

Review 1.  Citalopram versus other anti-depressive agents for depression.

Authors:  Andrea Cipriani; Marianna Purgato; Toshi A Furukawa; Carlotta Trespidi; Giuseppe Imperadore; Alessandra Signoretti; Rachel Churchill; Norio Watanabe; Corrado Barbui
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.